Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Phase 1 Study, Healthy Volunteers”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00093561
What this trial is testing

Lycopene in Preventing Prostate Cancer in Healthy Participants

Who this might be right for
Prostate Cancer
University of Illinois at Chicago
Early research (Phase 1)Study completedNCT06670170
What this trial is testing

Learn How Different Forms of the Study Medicine Called PF-07976016 Are Taken Up Into the Blood in Healthy Adults

Who this might be right for
Healthy Volunteers
Pfizer 12
Early research (Phase 1)Study completedNCT03398473
What this trial is testing

A Study Comparing The Effects Of Epoetin Hospira Single-Dose Vial (SDV) And Multi-Dose Vial (MDV) When Administered Subcutaneously To Normal Healthy Subjects

Who this might be right for
Healthy
Pfizer 68
Early research (Phase 1)Study completedNCT03230383
What this trial is testing

Assess The Safety, Tolerability, And Pharmacokinetics (PK) Of Multiple Doses Of PF-06865571 In Healthy, Including Overweight And Obese, Adult Subjects

Who this might be right for
Healthy Subjects
Pfizer 60
Early research (Phase 1)Active Not RecruitingNCT07254325
What this trial is testing

Pharmacokinetic, Safety and Immunogenicity Study of New Process CMAB015 and Cosentyx in Healthy Volunteers

Who this might be right for
Psoriasis
Taizhou Mabtech Pharmaceutical Co.,Ltd 114
Testing effectiveness (Phase 2)Study completedNCT04671017
What this trial is testing

Dose Finding Study to Evaluate The Safety, Tolerability and Immunogenicity of an Inactiviated, Adjuvanted SARS-CoV-2 Virus Vaccine Candidate Against Covid-19 in Healthy Subjects

Who this might be right for
SARS-CoV-2 Virus Infection
Valneva Austria GmbH 153
Early research (Phase 1)Active Not RecruitingNCT05501717
What this trial is testing

Safety, PK/PD, and Immunogenicity Study of SC ALXN2030 in Healthy Participants

Who this might be right for
Healthy
Alexion Pharmaceuticals, Inc. 48
Early research (Phase 1)Study completedNCT01124279
What this trial is testing

Single-dose, Pharmacokinetics of AMG 853 in Healthy Adult Subjects

Who this might be right for
Healthy Volunteers
Amgen 43
Early research (Phase 1)Not Yet RecruitingNCT07779980
What this trial is testing

Phase 1 Clinical Study of MWN110 Injection in Healthy Participants and Overweight or Obese Participants

Who this might be right for
Overweight , Obesity
Shanghai Minwei Biotechnology Co., Ltd 103
Early research (Phase 1)Study completedNCT06698861
What this trial is testing

A Phase I PK/PD Study of PEG-MetHuG-CSF (P2203) in Healthy Volunteers

Who this might be right for
PK in Healthy Volunteers
PharmaEssentia 30
Early research (Phase 1)Study completedNCT04967742
What this trial is testing

A Extension Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-612 COVID-19 Vaccine

Who this might be right for
COVID-19
United Biomedical Inc., Asia 50
Early research (Phase 1)Study completedNCT01452542
What this trial is testing

A Phase I Study of the Pharmacokinetic Variability and Relative Bioavailability of the Phase 3 and Common Blend Formulations of Eliglustat in Healthy Adult Subjects

Who this might be right for
Healthy Volunteer
Genzyme, a Sanofi Company 22
Early research (Phase 1)Study completedNCT06501586
What this trial is testing

Study of SGB-3908 in Healthy Subjects and Mildly Hypertensive Subjects

Who this might be right for
Hypertension,Essential
Suzhou Sanegene Bio Inc. 40
Early research (Phase 1)Study completedNCT06775327
What this trial is testing

Study to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, & Food Effect of Oral INCB000631 to Healthy Adult Participants

Who this might be right for
Healthy Participants
Incyte Corporation 71
Early research (Phase 1)Study completedNCT02681861
What this trial is testing

Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP6294 Administered Intravenously or Subcutaneously in Healthy Young Male and Female Subjects

Who this might be right for
Healthy SubjectsPharmacokinetics of ASP6294
Astellas Pharma Europe B.V. 74
Early research (Phase 1)Ended earlyNCT01298505
What this trial is testing

Investigate The Safety And Toleration Of Multiple Oral Doses Of PF-03654764 In Combination With Fexofenadine In Healthy Subjects

Who this might be right for
Healthy
Pfizer 36
Early research (Phase 1)Study completedNCT05447546
What this trial is testing

Study to Evaluate HT-6184 in Healthy Subjects

Who this might be right for
Normal Healthy Subjects
Halia Therapeutics, Inc. 64
Early research (Phase 1)Study completedNCT07030127
What this trial is testing

LY3985863 in Healthy Participants

Who this might be right for
Healthy
Eli Lilly and Company 24
Early research (Phase 1)Study completedNCT06190561
What this trial is testing

Learn How Different Products of the Study Medicine Called PF-07940367 Are Taken up Into the Blood in Healthy Adults

Who this might be right for
Healthy
Pfizer 40
Early research (Phase 1)Study completedNCT04680273
What this trial is testing

Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-GDC-9545 Following a Single Oral Dose (Part 1) and to Evaluate the Absolute and Relative Bioavailability of Oral Capsule Formulations of GDC-9545 (Part 2) in Healthy Female Subjects of Non-Childbearing Potential

Who this might be right for
Healthy Volunteers
Genentech, Inc. 16
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation